The oral thin films are especially suitable for patients with mental disorders, Alzheimer's disease, allergy immunotherapy, nicotine dependence, pain medication dependence, and other swallowing difficulties. Saliva stimulants are an essential ingredient in the formulation of oral thin films. The purpose of using saliva stimulant is to increase the rate of saliva production, which will help the oral thin film decompose faster. According to the nature of the drug ingredients, CD Formulation can provide professional saliva stimulant screening for oral thin film services.
Saliva stimulants tend to speed up the disintegration of formulations by increasing saliva intake. In general, saliva stimulants can usually be found in food-grade acids, citric acid, malic acid, lactic acid, ascorbic acid, and tartaric acid are several common salivary stimulants, with citric acid being the most popular.
Fig.1 Saliva stimulating agents, malic acid (22a), lactic acid (22b), ascorbic acid (22c), and tartaric acid (22d), (Manasa Chandramouli, et al., 2023)
CD Formulation based on the type of oral thin film, preparation process, and API properties, comprehensively evaluates and screens the most suitable saliva stimulant from the following aspects to ensure the quality and efficacy of oral thin films and achieve good therapeutic effects:
Saliva stimulants usually have a certain sour taste, we combine the flavoring agent and sweeteners in the oral thin film to evaluate the optimal saliva stimulant and the amount to add to obtain an oral thin film with good taste.
Different saliva stimulants will affect the production rate of saliva, and then affect the release of drugs. A typical in vitro dissolution test is used to evaluate the influence of saliva stimulants on film agents.
Saliva stimulants may react with some excipients, for example, citric acid will decompose into various products under heating conditions, and react with glycerin, alkali, etc. We will screen suitable saliva stimulants according to the preparation process of oral thin film and the properties of raw materials and excipients.
Technologies & Platform | Description |
In-vitro Dissolution Platform | In-vitro dissolution, drug release of the strip is determined by standard USP dissolution apparatus Type I (basket) and Type II (paddle). Sink conditions should be maintained during dissolution. Film might float over the medium during this operation, making it impossible to execute the test accurately. Because this problem is more likely to arise with the paddle approach, the basket equipment is most commonly used. 6.8 pH phosphate buffer (300 ml) and 0.1 N HCl were employed as media (900 ml). The temperature is normally kept around 37 ± 0.5℃, and the rotation speed is set at 50 rpm. At pre-determined intervals, samples of dissolved medication are collected and evaluated using a UV-spectrophotometer. |
Technology: Composition of the system
Journal: International Journal of ChemTech Research
IF: 5.8
Published: 2010
Results: Saliva-stimulating drugs are used to increase saliva production, which aids in the quick disintegration of orally dissolving strips. Salivary stimulants can be used alone or in conjunction with other medications to achieve the best results. Ascorbic acid, malic acid, citric acid, tartaric acid, and lactic acid are some of the most often utilized saliva-stimulating substances.
CD Formulation can bring the most professional saliva-stimulating screening technical guidance for customers. If you have a requirement about our saliva stimulating screening for oral thin film services, please contact us by phone or email, and our colleagues will reply to you within three working days.
References